76 related articles for article (PubMed ID: 18624006)
1. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase.
Gao Y; Wang M; Liu X
Microbiol Spectr; 2024 Apr; 12(4):e0394123. PubMed ID: 38426768
[TBL] [Abstract][Full Text] [Related]
2. Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa.
Shimakawa Y; Njie R; Ndow G; Vray M; Mbaye PS; Bonnard P; Sombié R; Nana J; Leroy V; Bottero J; Ingiliz P; Post G; Sanneh B; Baldeh I; Suso P; Ceesay A; Jeng A; Njai HF; Nayagam S; D'Alessandro U; Chemin I; Mendy M; Thursz M; Lemoine M
J Hepatol; 2018 Oct; 69(4):776-784. PubMed ID: 30104154
[TBL] [Abstract][Full Text] [Related]
3. DNA-guided hepatitis B treatment, viral load is essential, but not sufficient.
Bárcena Marugán R; García Garzón S
World J Gastroenterol; 2009 Jan; 15(4):423-30. PubMed ID: 19152446
[TBL] [Abstract][Full Text] [Related]
4. Importance of CHB's grey zone: analysis of patients with HBeAg negative chronic hepatitis B virus infection.
Lenartova PD; Hockickova I; Janicko M; Jarcuska P; Drazilova S; Lami F; Schreter I; Kristian P
Bratisl Lek Listy; 2024; 125(1):59-63. PubMed ID: 38041848
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Viral and Clinical Characteristics Among Patients With Chronic Hepatitis B Virus Infection in Georgia.
Zakalashvili M; Zarkua J; Metreveli D; Abzianidze T; Butsashvili M; Kamkamidze G
J Clin Exp Hepatol; 2023; 13(4):624-628. PubMed ID: 37440940
[TBL] [Abstract][Full Text] [Related]
6. A decision-making model for prediction of a stable disease course in chronic hepatitis B patients.
Ofri I; Peleg N; Leshno M; Shlomai A
Sci Rep; 2023 Dec; 13(1):23051. PubMed ID: 38155298
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study to determine the correlation among HBV PreS1 antigen, HBV e antigen, alanine aminotransferase, and HBV DNA.
Du S; Shen X; Sun Y; Li J; Wang J; Cai Y; Li H
Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102369. PubMed ID: 38719147
[TBL] [Abstract][Full Text] [Related]
8. Postpartum care for mothers diagnosed with hepatitis B during pregnancy.
Chang MS; Tuomala R; Rutherford AE; Mutinga ML; Andersson KL; Burman BE; Brown RS; Oken E; Ukomadu C
Am J Obstet Gynecol; 2015 Mar; 212(3):365.e1-7. PubMed ID: 25281364
[TBL] [Abstract][Full Text] [Related]
9. Diabetes and prediabetes in patients with hepatitis B residing in North America.
Khalili M; Lombardero M; Chung RT; Terrault NA; Ghany MG; Kim WR; Lau D; Lisker-Melman M; Sanyal A; Lok AS;
Hepatology; 2015 Nov; 62(5):1364-74. PubMed ID: 26390278
[TBL] [Abstract][Full Text] [Related]
10. Characterization and assessment of HBV chronically infected patients: Identification of those eligible for treatment in the South West region of Cameroon.
Tufon KA; Anong DN; Meriki HD; Georges TD; Maurice M; Kouanou YS; Bolimo AF; Tony NJ; Kwenti TE; Wung NH; Nkuo-Akenji T
PLoS One; 2018; 13(9):e0203312. PubMed ID: 30183765
[TBL] [Abstract][Full Text] [Related]
11. Nursing observations of stage-based care in patients diagnosed with hepatitis B virus infection based on TBIL and ALT levels.
Lin Y; Wu B; Lin P; Zhang L; Li W
Medicine (Baltimore); 2024 May; 103(21):e38072. PubMed ID: 38788000
[TBL] [Abstract][Full Text] [Related]
12. Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK.
Campbell C; Wang T; Smith DA; Freeman O; Noble T; Várnai KA; Harris S; Salih H; Roadknight G; Little S; Glampson B; Mercuri L; Papadimitriou D; Jones CR; Taylor V; Chaudhry A; Phan H; Borca F; Olza J; Warricker F; Romão L; Ramlakhan D; English L; Klenerman P; Andersson MI; Collier J; Nastouli E; Khakoo SI; Gelson W; Cooke GS; Woods K; Davies J; Barnes E; Matthews PC
Wellcome Open Res; 2022; 7():51. PubMed ID: 38721280
[TBL] [Abstract][Full Text] [Related]
13. Urgent need for lived experience in hepatitis B guideline development.
Freeland C; Lo W; Kabagambe K; Wang S; Adda D; Graham CS; Gish R; Cohen C
Lancet Gastroenterol Hepatol; 2024 Apr; 9(4):282-284. PubMed ID: 38272054
[No Abstract] [Full Text] [Related]
14. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
Veldhuijzen IK; Mostert MC; Niesters HG; Richardus JH; de Man RA
Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1426-30. PubMed ID: 18624006
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B.
Jeng WJ; Sheen IS; Liaw YF
Clin Gastroenterol Hepatol; 2010 Jun; 8(6):541-5. PubMed ID: 20298811
[TBL] [Abstract][Full Text] [Related]
16. Markers of disease activity in chronic hepatitis B virus infection.
Yalcin K; Degertekin H; Yildiz F; Celik Y
Clin Invest Med; 2003 Feb; 26(1):27-34. PubMed ID: 12659467
[TBL] [Abstract][Full Text] [Related]
17. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
van der Eijk AA; Niesters HG; Hansen BE; Heijtink RA; Janssen HL; Schalm SW; de Man RA
J Viral Hepat; 2006 Feb; 13(2):96-103. PubMed ID: 16436127
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of chronic hepatitis B: an update.
Morgan M; Park W; Keeffe EB
Minerva Gastroenterol Dietol; 2007 Mar; 53(1):25-41. PubMed ID: 17415343
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
